New Evidence of the Enhanced Elimination of a Persistent Drug Used as a Lipid Absorption Inhibitor by Advanced Oxidation With UV-A and Nanosized Catalysts
Catalysts - Switzerland
doi 10.3390/catal9090761
Full Text
Open PDFAbstract
Available in full text
Date
September 11, 2019
Authors
Publisher
MDPI AG